FDA Paves Way For Pfizer COVID-19 Vaccinations For Kids Ages 5 To 11

The FDA has approved the emergency use of Pfizer's COVID-19 vaccine for children aged 5 to 11, making it available to 28 million kids in the US. This approval follows a quick process, with the FDA typically acting shortly after its advisory panel's recommendations. The CDC is expected to issue its own recommendations soon, potentially allowing vaccinations to begin as early as next week. The vaccine is reported to be 90% effective in protecting children from COVID-19, and while the approval process is fast, safety and efficacy remain priorities.

What age group has the FDA approved Pfizer's COVID-19 vaccine for emergency use?

• 12 to 15 years

• 16 to 18 years

• 3 to 5 years

• 5 to 11 years

What is the difference between emergency authorization and full approval by the FDA?

• Emergency authorization is permanent, full approval is temporary.

• Emergency authorization allows flexibility, full approval is more stringent.

• There is no difference between the two.

• Full approval is faster than emergency authorization.

What is the next step after the FDA's emergency authorization for the vaccine?

• Distribution to pharmacies

• CDC's advisory panel meeting

• Approval by the President

• Immediate public availability

When are the first vaccinations for children expected to start?

• Next year

• In two weeks

• Next month

• Next week

What is the reported efficacy of the vaccine in protecting children from COVID-19?

• 70%

• 80%

• 90%

• 100%